Elevance Health (NYSE:ELV) Rating Lowered to Hold at StockNews.com
Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...
How this $5.5-billion dividend fund manager is navigating volatile markets
Daneshvar Rohinton of iA Global Asset Management is expecting an economic realignment as many countries look at becoming more ...
Investing Snacks14h
Elevance Exec Sells $1.4M in Stock—Should Investors Worry?
Elevance Health’s Executive VP Charles Kendrick sold $1.4M worth of stock, reducing his stake by 40%. While insider sales can ...
Elevance Health Inc. stock outperforms competitors on strong trading day
Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.
Experts propose new approach for bridging the gap between administrative and clinical priorities
In a recently published Perspective article in the New England Journal of Medicine, Marisha Burden, MD, MBA, and Liselotte ...
Innovators of the Year for Senior Health: Improving Care Through Improv, Fayron Epps and Dr. Ugochi Ohuabunwa
Meet the Innovators of the Year for Senior Health honorees for Atlanta Business Chronicle's Health Care Champion Awards.